Health Catalyst Inc expected to post a loss of 21  cents a share - Earnings Preview

Health Catalyst

25/02/2022 23:07

* Health Catalyst Inc  HCAT.OQ   HCAT.O  is expected to show
a
rise in quarterly revenue when it reports  results on March 1. 
    * The South Jordan Utah-based  company is expected to report
 a
18.5% increase in revenue to $63.145 million from $53.28 million
a year ago, according to the mean estimate from 12 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Health Catalyst Inc
is
for a loss of 21 cents per share. For the same quarter last
year, the company reported a loss of 16 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Health
Catalyst
Inc is $61​, about 55.4% above​ its last closing price
of $27.19. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.21       -0.22      -0.18     Beat    17.2
 Jun. 30 2021  -0.14       -0.14      0.00      Beat    100
 Mar. 31 2021  -0.13       -0.15      -0.06     Beat    59.2​
 Dec. 31 2020  -0.17       -0.19      -0.16     Beat    17.1
 ​​Sep.        -0.27       -0.27      -0.21     Beat    21.9
 30 2020                                                
 Jun. 30 2020  -0.21       -0.22      -0.15     Beat    32.7​
 Mar. 31 2020  -0.23       -0.25      -0.16     Beat    36.8
 Dec. 31 2019  -0.28       -0.29      -0.21     Beat    27.6
 This summary was machine generated February 25 at 23:07 GMT. 
All figures in US dollars  unless otherwise stated